UNSPSC 51181500: Antidiabetic agents and hyperglycemic agents

This classification denotes agents which lower the blood glucose level.

UNSPSC 51181500 Antidiabetic agents and hyperglycemic agents is a Class code covering pharmaceutical products used to manage diabetes and blood glucose levels, procured by state and local governments through cooperative purchasing vehicles and direct supply agreements. State and local health departments, correctional facilities, public hospitals, and other government-operated healthcare settings purchase these agents as part of formulary management and pharmaceutical supply programs. The work involves establishing vendor contracts for generic and brand-name antidiabetic medications with specified National Drug Codes, pricing structures, and wholesale distribution arrangements. Vendors must demonstrate cGMP certification, Drug Supply Chain Security Act compliance, established relationships with authorized pharmaceutical wholesalers, and the ability to provide detailed product data including NDC codes, packaging configurations, and shelf-life documentation.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products serving participating state and local government facilities across Minnesota and Oregon. The MMCAP solicitation (S1070000015802) closed March 26, 2026, and evaluates proposals based primarily on price competitiveness (75 percent weight), with secondary consideration for fixed pricing structure (10 percent), compliance with administrative and EDI requirements (5 percent each), and acceptance of a 3 percent administrative fee (5 percent). Vendors must maintain contractual relationships with at least two of three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and carry insurance coverage including $5 million general liability, $2 million network security and privacy liability, and $2 million professional liability. Awarded vendors will supply products effective July 1, 2026, under two-year initial terms for new responders with optional extensions at MMCAP's discretion.